Remo Poto Selected Research

Remo Poto Research Topics

Disease

12	Asthma (Bronchial Asthma) 04/2024 - 11/2019
8	Neoplasms (Cancer) 11/2023 - 01/2020
5	Inflammation (Inflammations) 05/2024 - 01/2022
4	Common Variable Immunodeficiency 10/2023 - 11/2019
3	Chronic Obstructive Pulmonary Disease (COPD) 05/2024 - 01/2022
3	Cardiotoxicity 01/2023 - 01/2021
2	Rhinosinusitis 01/2024 - 01/2021
2	Nasal Polyps (Nasal Polyp) 01/2024 - 01/2021
2	Infections 10/2023 - 01/2023
2	Atopic Dermatitis (Atopic Eczema) 08/2023 - 01/2022
2	COVID-19 02/2023 - 01/2022
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2020
2	Eosinophilia 06/2021 - 11/2019
2	Polyps 06/2021 - 01/2021
1	Mastocytosis 11/2023
1	Immune System Diseases (Immune Disorders) 08/2023
1	Hypersensitivity (Allergy) 07/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Infarction (Infarctions) 01/2023
1	Heart Failure 12/2022
1	Airway Remodeling 12/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Chronic Urticaria 01/2022
1	Vasculitis (Vasculitides) 06/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Hepatomegaly 11/2019
1	Respiratory Hypersensitivity 11/2019

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 05/2024 - 11/2019
6	Monoclonal AntibodiesIBA 11/2022 - 11/2019
5	Immunoglobulin E (IgE)IBA 08/2023 - 11/2019
4	Thymic Stromal LymphopoietinIBA 04/2024 - 11/2019
3	mepolizumabIBA 05/2024 - 01/2021
3	AlarminsIBA 05/2024 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 05/2022
3	Immunoglobulins (Immunoglobulin)IBA 10/2023 - 01/2023
3	Immunoglobulin G (IgG)IBA 08/2023 - 01/2021
2	tezepelumabIBA 05/2024 - 11/2019
2	Interleukin-33IBA 05/2024 - 11/2022
2	Interleukin-13IBA 05/2024 - 11/2022
2	Tryptases (Tryptase)IBA 11/2023 - 08/2023
2	anti-IgE antibodiesIBA 08/2023 - 01/2022
2	AutoantibodiesIBA 08/2023 - 01/2022
2	Immunoglobulin A (IgA)IBA 07/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2022
2	AngiopoietinsIBA 12/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 06/2021 - 01/2021
1	benralizumabIBA 05/2024
1	astegolimabIBA 05/2024
1	itepekimabIBA 05/2024
1	dupilumabIBA 05/2024
1	Prostaglandin D2IBA 08/2023
1	Leukotriene C4IBA 08/2023
1	LipidsIBA 08/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 08/2023
1	cysteinyl-leukotrieneIBA 08/2023
1	Proteins (Proteins, Gene)FDA Link 02/2023
1	lipoxin A4IBA 01/2023
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2023
1	Nucleosomes (Nucleosome)IBA 01/2023
1	LigandsIBA 01/2023
1	Therapeutic UsesIBA 12/2022
1	Vascular Endothelial Growth FactorsIBA 12/2022
1	Secretory Phospholipases A2IBA 12/2022
1	Immunologic Factors (Immunomodulators)IBA 11/2022
1	ChemokinesIBA 11/2022
1	Histones (Histone)IBA 11/2022
1	Peroxidase (Myeloperoxidase)IBA 11/2022
1	GlucocorticoidsIBA 05/2022
1	Vascular Endothelial Growth Factor CIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	SmokeIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 06/2021
1	atezolizumabIBA 06/2021
1	NivolumabIBA 06/2021
1	IpilimumabIBA 06/2021
1	pembrolizumabIBA 06/2021
1	avelumabIBA 06/2021
1	cemiplimabIBA 06/2021
1	durvalumabIBA 06/2021
1	Interleukin-3 (Interleukin 3)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	VaccinesIBA 01/2020
1	EnzymesIBA 11/2019

Therapy/Procedure

6	Therapeutics 07/2023 - 11/2019
2	Precision Medicine 05/2024 - 07/2023
2	Biological Therapy 01/2024 - 11/2019
2	Immunotherapy 01/2023 - 06/2021